Request Demo
Last update 23 Oct 2025
AI-061
Last update 23 Oct 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms AI-025/ONC-392, AI-061 |
Target |
Action inhibitors |
Mechanism CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 680751063L
The sequence is quoted from: *****
Sequence Code 785813310H
The sequence is quoted from: *****
Related
1
Clinical Trials associated with AI-061NCT05858736
Safety, Pharmacokinetics (PK) and Efficacy of AI-061, A 1:1 Co-formulation of AI-025 (Anti-PD-1) and ONC-392 (Anti-CTLA-4) Antibodies in Advanced Solid Tumors: An Open-Label Phase 1 Study
100 Clinical Results associated with AI-061
Login to view more data
100 Translational Medicine associated with AI-061
Login to view more data
100 Patents (Medical) associated with AI-061
Login to view more data
100 Deals associated with AI-061
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | Australia | 11 Jul 2023 | |
| Anus Neoplasms | Phase 1 | Australia | 11 Jul 2023 | |
| Bile Duct Neoplasms | Phase 1 | Australia | 11 Jul 2023 | |
| Bladder Cancer | Phase 1 | Australia | 11 Jul 2023 | |
| Endometrial Carcinoma | Phase 1 | Australia | 11 Jul 2023 | |
| Esophageal Carcinoma | Phase 1 | Australia | 11 Jul 2023 | |
| Fallopian Tube Carcinoma | Phase 1 | Australia | 11 Jul 2023 | |
| Gastrooesophageal junction cancer | Phase 1 | Australia | 11 Jul 2023 | |
| Hepatocellular Carcinoma | Phase 1 | Australia | 11 Jul 2023 | |
| high grade serous adenocarcinoma of ovary | Phase 1 | Australia | 11 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free